Travere Therapeutics

About:

Travere discovers and develops drugs for the treatment of catastrophic diseases that are debilitating and often life-threatening.

Website: https://travere.com/

Twitter/X: travererare

Top Investors: Athyrium Capital Management LP

Description:

Travere Therapeutics is advancing therapeutic candidates for rare disorders in nephrology, hepatology and metabolism; sponsoring no-cost genetic testing aimed at improving the diagnostic odyssey for children born with cholestasis; partnering with patient advocacy organizations to meet the diverse needs of patients and their families; and ensuring broad access and education for its FDA-approved therapies.